Aerovate Therapeutics, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
Jade Biosciences, Inc. has issued its proxy statement, inviting stockholders to its 2026 Annual Meeting of Stockholders on June 9, 2026, to vote on director elections, auditor ratification, and a charter amendment.
Aerovate Therapeutics will hold its annual stockholders meeting on June 5, 2024, to vote on the election of directors and the ratification of KPMG LLP as the company's independent accounting firm.
Aerovate Therapeutics announces its 2024 Annual Meeting of Stockholders to be held on June 5, 2024, to elect directors and ratify the appointment of KPMG LLP as the independent accounting firm.